EU-Regulierungsbehörden und WHO fordern das Ende von COVID-19-Booster-Impfungen, da die Strategie nachweislich keinen Erfolg habe

Die EU-Arzneimittelbehörden, Experten der Weltgesundheitsorganisation und der ehemalige Vorsitzende der britischen COVID-19-Taskforce verwiesen alle auf die zunehmenden Hinweise darauf, dass die mRNA-Booster-Impfungen gegen COVID-19 nicht wirken und die Strategie aufgegeben werden sollte.

Ivermectin for COVID-19: real-time meta analysis of 65 studies

Ivermectin is an effective treatment for COVID-19. Treatment is more effective when used early. Meta analysis using the most serious outcome reported shows 66% [53‑76%] and 86% [75‑92%] improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis and restriction to peer-reviewed studies or Randomized Controlled Trials.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests

The COVID-19 pandemic caused increased mortality in nursing homes due to its quick spread and the age-related high lethality.

Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities

The clinical experience of this case series indicates DOXY-HCQ treatment in high-risk COVID-19 patients is associated with a reduction in clinical recovery, decreased transfer to hospital, and decreased mortality were observed after treatment with DOXY-HCQ.

COVID-19 mortality risk factors in older people in a long-term care center

Male gender, low Barthel index, and lymphocytopenia are independent risk factors for COVID-19 mortality in institutionalized older patients in long-term care nursing homes. Treatment with hydroxychloroquine and azithromycin was associated with lower mortality in these patients.

Effectiveness of a On-site Medicalization Program for Nursing Homes With COVID-19 Outbreaks

A coordinated on-site MP of nursing homes with COVID-19 outbreaks achieved a higher SOPC rate, and a reduction in referrals to hospital, thus ensuring rigorous but also humanistic and gentle care to residents.

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Chloroquine and hydroxychloroquine have been found to be efficient on SARS-CoV-2 and reported to be efficient in Chinese COV-19 patients. We evaluate the effect of hydroxychloroquine on respiratory viral loads.

Assessment of COVID-19 Treatment containing both Hydroxychloroquine and Azithromycin: A natural clinical trial

This natural trial showed that the COVID-19 regimen containing both HCQ and azithromycin can be helpful to promote the recovery of most patients and reduced their signs and symptoms significantly.

Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review

Evidence is not sufficiently strong to either promote or refute the efficacy of IVM, DOXY, or their combination in COVID-19 management.

Ivermectin: an award-winning drug with expected antiviral activity against COVID-19

Ivermectin is an FDA-approved antiparasitic agent, being currently investigated in COVID-19 patients.

A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness

The authors declare that there are no known competing financial interests or personal relationships that could have appeared to influence the work described in this paper.

Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed therapeutic agents were used empirically and studied within clinical trials.

Mehr als 40 Ärzte erklären gegenüber britischer Arzneimittelbehörde: COVID-19-Impfung für Kinder ist „unverantwortlich, unethisch und unnötig“

In einem offenen Brief an die MHRA weisen mehr als 40 Ärzte, Mediziner und Wissenschaftler in Großbritannien darauf hin, dass Kinder anfälliger für die möglichen Spätfolgen von COVID-19-Impfstoffen sind.

Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial

We examined whether existing licensed pharmacotherapies could reduce the spread of coronavirus disease 2019 (COVID-19).

Dänemark gibt COVID-19-Impfstoff von J&J den Laufpass – Nutzen „überwiegt nicht das Risiko“ von Blutgerinnseln

Die dänische Gesundheitsbehörde gab heute unter Berufung auf einen möglichen Zusammenhang mit dem Auftreten von Blutgerinnseln bekannt, dass der Impfstoff von Johnson & Johnson nicht zum Einsatz kommen werde. Dieser Schritt folgt auf die Entscheidung im vergangenen Monat, den Impfstoff von AstraZeneca aufgrund ähnlicher Bedenken aus dem Verkehr zu ziehen.

Wissenschaftler kontern Aussage der WHO, es sei „extrem unwahrscheinlich“, dass COVID-19 aus einem Labor stamme

Eine von China und der WHO durchgeführte Studie über die Ursprünge von COVID-19 kam zu dem Schluss, dass das Virus „höchstwahrscheinlich“ von Fledermäusen über ein anderes Tier auf den Menschen übertragen wurde. Aus Medienberichten geht allerdings hervor, dass viele Wissenschaftler dieser Theorie und der Untersuchung skeptisch gegenüberstehen.

Increased risk for Covid-19 in patients with Vitamin D deficiency.

Vit D deficiency increased likelihood of being COVID-19 positive by 4.6 times.

Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.

Hospitalized COVID-19 patients with diabetes had a 85.7% lower death rate when given Vit D.

Nutrients, Low 25-Hydroxyvitamin D Levels on Admission to the Intensive Care Unit May Predispose COVID-19 Pneumonia Patients to a Higher 28-Day Mortality Risk: A Pilot Study on a Greek ICU Cohort.

Observational study showing improved immune system activity if supplementation was given to Vit D insufficient and deficient patients.

Nutrients, High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study.

An 80% decrease in death among hospitalized (late treatment) patients in the UK given Vitamin D.

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests.

Italian nursing home patients given Vitamin D before being exposed to COIVD 19 had a 70% decrease in death.

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19).

Early treatment of COVID-19 with sequential multidrug treatment (SMDT) that has been shown to be safe and effective for non-hospitalized patients with symptoms of COVID 19.

Vitamin D Status is Associated With In-hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients

Patients with higher Vitamin D levels had significantly lower death rate.

Der MMR II-Impfstoff schützt nicht vor schweren COVID-19-Fällen

Der fehlende Schutz durch den Mumps-Anteil des MMR-II-Impfstoffs ist so spektakulär, dass er Gegenstand einer Klage aufgrund falscher Behauptungen ist, die von der Bundesregierung gegen den MMR-II-Hersteller und Pharmariesen Merck angenommen wurde.

Commentary: Informed consent disclosure to vaccine trial subjects of risk of COVID-19 vaccines worsening clinical disease

The risk antibody‐dependent enhancement (ADE) during COVID-19 vaccine trials was sufficiently obscured in clinical trial protocols and consent forms that adequate patient comprehension of this risk is unlikely to occur, obviating truly informed consent by subjects in these trials.

Prospects for a safe COVID-19 vaccine

Although animal models of SARS-CoV-2 infection may elucidate mechanisms of immune protection, we need observations of enhanced disease in people receiving candidate COVID-19 vaccines to understand the risk of immune enhancement of disease. Neither principles of immunity nor preclinical studies provide a basis for prioritizing among the COVID-19 vaccine candidates with respect to safety at this time.

Positive association between COVID-19 deaths and influenza vaccination rates in elderly people worldwide

There is a positive association between COVID-19 deaths and Influenza Vaccination Rate (IVR) of people ≥65 years-old.

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

The activity of hydroxychloroquine on viruses is probably the same as that of chloroquine since the mechanism of action of these two molecules is identical so there is a strong rationality for the use of chloroquine to treat SARS-CoV-2-related pneumonia (named COVID-19).

Fünf Theorien zum Ursprung von Omikron, der Variante, die die Pandemie beenden könnte

Woher auch immer Omikron herstammt, die gute Nachricht ist, dass es höchst überlebensfähig ist und das Ende der COVID-Pandemie bedeuten könnte.

Was Djokovic’s Kampf um die Teilnahme an den Australian Open für die Bewegung für Gesundheitsfreiheit bedeutet

Wenn dem serbischen Tennisstar erlaubt wird, im Land zu bleiben und an den Australian Open teilzunehmen, wird der australische Premierminister zugeben, dass die Gesundheitspolitik seines Landes von Anfang an unsinnig und wenig differenziert war.